help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2005-0074
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casas, F.
Right arrow Articles by Cabello, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casas, F.
Right arrow Articles by Cabello, G.
Molecular Endocrinology 20 (4): 749-763
Copyright © 2006 by The Endocrine Society

Characterization of a Novel Thyroid Hormone Receptor {alpha} Variant Involved in the Regulation of Myoblast Differentiation

François Casas, Muriel Busson, Stéphanie Grandemange, Pascal Seyer, Angel Carazo, Laurence Pessemesse, Chantal Wrutniak-Cabello and Gérard Cabello

Unité Mixte de Recherche-866 Différenciation Cellulaire et Croissance [Institut National de la Recherche Agronomique (INRA)-Université Montpellier II-Ecole Nationale Supérieure Agronomique de Montpellier], INRA, 34060 Montpellier Cedex 1, France

Address all correspondence and requests for reprints to: François Casas, Unité Mixte de Recherche-866 Différenciation Cellulaire et Croissance, Institut National de la Recherche Agronomique (INRA), 2 place Viala, 34060 Montpellier Cedex 1, France. E-mail: casasf{at}ensam.inra.fr.

The regulation of gene expression by thyroid hormone (T3) involves binding of the hormone to nuclear receptors [thyroid hormone receptor (TR)] acting as T3-dependent transcription factors encoded by TR{alpha} (NR1A1) and TRß (NR1A2) genes. Several TR{alpha} variants have already been characterized, but only some of them display T3 binding activity. In this study, we have identified another transcript, TR{alpha}-{Delta}E6, produced by alternative splicing with microexon 6b instead of exon 6. This splicing leads to the synthesis of a protein devoid of a hinge domain. The TR{alpha}-{Delta}E6 transcript is detected in all mouse tissues tested. Although TR{alpha}-{Delta}E6 did not bind DNA, its expression induced a TR{alpha}1 sequestration in the cytoplasm. Functional studies demonstrated that TR{alpha}-{Delta}E6 inhibits the transcriptional activity of TR{alpha}1 and retinoic X receptor-{alpha}, but not of retinoic acid receptor-{alpha}. We also found that TR{alpha}-{Delta}E6 efficiently decreased the ability of TR{alpha} to inhibit MyoD transcriptional activity during myoblast proliferation. Consequently, when overexpressed in myoblasts, it stimulated terminal differentiation. We suggest that this novel TR{alpha} variant may act as down regulator of overall T3 receptor activity, including its ability to repress MyoD transcriptional activity during myoblast proliferation.

NURSA Molecule Pages Link:

Nuclear Receptors:   TRα  |  RXRα
Ligands:   all-trans-Retinoic acid  |  9-cis-Retinoic acid  |  Thyroid hormone



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
F. Flamant, K. Gauthier, and J. Samarut
Thyroid Hormones Signaling Is Getting More Complex: STORMs Are Coming
Mol. Endocrinol., February 1, 2007; 21(2): 321 - 333.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society